Fursultiamine in Esophageal Squamous Cell Carcinoma Patients Who Receive Concurrent Chemoradiotherapy
NCT02423811
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Cancer Stem Cell
Interventions
DIETARY_SUPPLEMENT:
Fursultiamine
Sponsor
National Cheng-Kung University Hospital